BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 1 day ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 1 day ago UP Fintech Holding Limited Reports Strong 2025 Results 1 day ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 1 day ago Cato Corporation 2025 Financial Results Summary 1 day ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 1 day ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 1 day ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 1 day ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 1 day ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 1 day ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 1 day ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 1 day ago UP Fintech Holding Limited Reports Strong 2025 Results 1 day ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 1 day ago Cato Corporation 2025 Financial Results Summary 1 day ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 1 day ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 1 day ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 1 day ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 1 day ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 1 day ago
ADVERTISEMENT
VRTX

All VRTX Content

35 articles, transcripts, and reports

ADVERTISEMENT
ADVERTISEMENT
Alphastreet Vertex Pharma Q4 2025 Earnings Results
Earnings

Vertex Pharma Q4 2025 Earnings Results

Vertex Pharmaceuticals reported solid financial results for the fourth quarter of 2025, driven by continued demand for its cystic fibrosis...

2 min read